Rob Davis, Merck CEO (Jeenah Moon/Bloomberg via Getty Images)
Merck’s Gardasil sales sink further amid China market pressure
Sales of Merck’s HPV vaccine plummeted 41% in the first quarter, as the company continues to deal with lower demand in China.
Gardasil is Merck� …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
